E-Compared-CH: Comparative Effectiveness Research on Internet-based Depression Treatment - Swiss Trial

University of Bern50 enrolled

Overview

To compare the clinical and cost-effectiveness of blended Cognitive Behavioural Therapy (CBT) for adults with major depressive disorder (MDD) with treatment as usual (TAU) in Swiss patients in secondary care

Background Depression is a common mental disorder with a negative impact on mental well-being, quality of life, and social and work-related functioning both in the short and longer term. Additionally, depression is associated with increased morbidity, mortality, health care utilization and health care costs. On a population level, depression is one of the most costly diseases. The economic costs of depression were estimated at €136.3 billion (EU25) in 2010 in the EU and are still rising. European health care systems face the challenge of improving access to cost-effective treatments while simultaneously working to sustain budgetary stability in times of economic austerity. Internet-based depression treatment appears a very promising alternative to current routine depression treatment strategies. Meta-analyses have demonstrated the clinical effectiveness and potential cost-effectiveness of Internet-based treatment for depression in controlled research setting. Internet-based treatment thus has the potential to keep depression treatment affordable, as it enables mental health care providers to reach out to large populations needing depression treatment at a better cost-effectiveness than those of standard treatment as usual (TAU), but with similar levels of clinical efficacy and quality of care. The trials will be conducted in 8 European countries. Objective To compare the clinical and cost-effectiveness of blended CBT and TAU in secondary care Methods In Switzerland, a randomized-controlled trial will be carried out in secondary care, comparing the clinical and cost-effectiveness of CBT and TAU for adults with major depressive disorder (MDD). Respondents will be followed until 12 months after baseline (measures will be taken at BL, 12 weeks, 18 weeks, 6 months and 12 months).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Depressive Disorder, Major

Interventions

Blended CBTBEHAVIORAL

Internet based blended CBT depression treatment combines individual face-to-face cognitive behavioural therapy (CBT) with CBT delivered through an Internet based treatment platform with mobile phone components. The core components of the CBT treatment are: (1) psychoeducation, (2) behavioural activation, (3) cognitive restructuring, and (4) relapse prevention.

Treatment as usualBEHAVIORAL

Treatment as usual (TAU) is defined as the routine care that subjects receive when they are diagnosed with depression in the secondary care system. The investigators will not interfere with treatment as usual but they will monitor carefully which health care services are utilized by usual care patients using patient records and through self-report.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Being 18 years of age or older * Meet DSM-IV diagnostic criteria for MDD confirmed by MINI International Neuropsychiatric Interview version 5.0 * Informed Consent * Having access to a PC and Internet connection * Having a Smartphone that is compatible with the mobile component of the intervention * Understanding of the German language spoken and written Exclusion Criteria * Current high risk for suicide according to the MINI Interview section C * Serious psychiatric co-morbidity: substance dependence, bipolar affective disorder, psychotic illness, obsessive compulsive disorder, as established at the MINI interview * Currently receiving psychological treatment for depression * Being unable to comprehend the spoken and written language (German) * Not having access to a PC and fast Internet connection (i.e. broadband or comparable). * Not having a Smartphone that is compatible with the mobile component of the intervention that is offered or not willing to carry a Smartphone during the duration of treatment

Locations (2)

Sanatorium Kilchberg

Kilchberg, Canton of Zurich, Switzerland

Department of Clinical Psychology and Psychotherapy

Bern, Switzerland

Outcomes

Primary Outcomes

Patient Health Questionnaire-9 (PHQ-9)

Time frame: 18 weeks

Secondary Outcomes

Assessment of Quality of Life (AQoL-6D)

Time frame: Baseline, 12 weeks, 18 weeks, 6 months, and 12 months

Quick Inventory of Depressive Symptomatology Self-Report (QIDS-16-SR)

Time frame: Baseline, 12 weeks, 18 weeks, 6 months, and 12 months

MINI International Neuropsychiatric Interview (M.I.N.I; Ackenheil et al., 1999)

Time frame: Baseline, 18 weeks, and 12 months

EuroQoL (EQ-5D-5L; Herdman et al., 2011)

Time frame: Baseline, 12 weeks, 18 weeks, 6 months, and 12 months

Questionnaires on Costs Associated with Psychiatric Illness (TiC-P; Hakkaart-van Rooijen, van Straten, Donker, Tiemens, 2002)

Time frame: Baseline, 12 weeks, 18 weeks, 6 months, and 12 months

Client Satisfaction Questionnaire (CSQ-8; Nguyen, Attkinson, & Stegner, 1983)

Time frame: 12 weeks, and 18 weeks

System Usability Scale (SUS; Brooke, 1996)

Time frame: 12 weeks, and 18 weeks

Patient Health Questionnaire-9 (PHQ-9)

Time frame: Baseline, 12 weeks, 6 months, and 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.